HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary Budd-Chiari syndrome in a 3-year-old boy with homozygous factor V Leiden G1691A mutation.

AbstractUNLABELLED:
Budd-Chiari syndrome (BCS) is an uncommon disorder characterized by obstruction of hepatic venous outflow. The primary BCS is a rare disease with an incidence about 0.2 per million inhabitants per year. We present a 3-year-old boy with intrahepatic inferior vena cava clot. Because of decreased levels of protein C (38.7 %), F II (69.1 %), and activated protein C resistance (1.43), a mutational gene analysis was performed. The patient was found to be homozygous for the FV G1691A mutation.
CONCLUSION:
The primary BCS is a rare disease especially in childhood. Activated protein C resistance caused by the factor V Leiden mutation may be responsible for primary BCS. Prompt recognition of underlying prothrombotic disease and early initiation of their specific therapy might translate into rapid improvement of liver disease.
AuthorsAleksandra Boskovic, Ivana Kitic, Ivica Stankovic, Dragan Prokic, Nada Zlatar
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 173 Issue 3 Pg. 393-5 (Mar 2014) ISSN: 1432-1076 [Electronic] Germany
PMID23677252 (Publication Type: Case Reports, Journal Article)
Chemical References
  • factor V Leiden
  • Factor V
Topics
  • Budd-Chiari Syndrome (diagnosis, genetics)
  • Child, Preschool
  • DNA Mutational Analysis
  • Factor V (genetics)
  • Homozygote
  • Humans
  • Male
  • Mutation
  • Vena Cava, Inferior (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: